AMRN240816C1000
- 0.01
- 0.000.00%
Amarin Newsroom
Amarin Corporation Plc's (NASDAQ:AMRN) Intrinsic Value Is Potentially 29% Above Its Share Price
European Equities Traded in the US as American Depositary Receipts Trend Lower Thursday
European equities traded in the US as American depositary receipts were moving moderately lower late Thursday morning, declining 0.72% to 1,423.26 on the S&P Europe Select ADR Index.From continental
Sector Update: Health Care Stocks Edge Lower Premarket Thursday
Health care stocks were lower premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) 0.1% down and the iShares Biotechnology ETF (IBB) marginally declining recently.OPKO Health (OPK)
Amarin Says Vazkepa Secures National Reimbursement in Portugal
Amarin (AMRN) said late Wednesday the Portuguese Ministry of Health has approved Vazkepa for national reimbursement to lower the risk of cardiovascular events in adult patients.The company said the
Express News | Amarin Shares Are Trading Higher After the Company Received National Reimbursement for VAZKEPA in Portugal
Express News | Portuguese Ministry Of Health Approves VAZKEPA For National Reimbursement To Reduce Cardiovascular Risk In High-Risk Patients; Eighth National Reimbursement In Europe; Amarin To Begin Commercialization In Portugal On August 1, 2024
Express News | Amarin Receives National Reimbursement for Vazkepa® (Icosapent Ethyl) in Portugal
Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 0.22% to 1,450.44 on the S&P Europe Select ADR Index.From continental Europe, the
European Equities Traded in the US as American Depositary Receipts Climb Higher in Friday Trading
European equities traded in the US as American depositary receipts were higher late Friday morning, rising 1.39% to 1,473.10 on the S&P Europe Select ADR Index. The index is set to end the week
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
European equities traded in the US as American depositary receipts were trending slightly higher late Thursday morning, rising 0.19% to 1,460.27 on the S&P Europe Select ADR Index.From continental
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.73% to 1,446.60 on the S&P Europe Select ADR Index.From continental Europe,
European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading
European equities traded in the US as American depositary receipts started the week off on a flat note late Monday morning, nudging 0.002% higher to 1,452.10 on the S&P Europe Select ADR Index.From co
Sector Update: Health Care Stocks Edge Higher Premarket Monday
Health care stocks were edging higher premarket Monday as the Health Care Select Sector SPDR Fund (XLV) was advancing 0.1% and the iShares Biotechnology ETF (IBB) was up 0.6% recently.Morphic Holding
Amarin Commercial Partner in China Receives Regulatory Approval for Heart Drug Vascepa
Amarin (AMRN) said Monday China's National Medical Products Administration has granted an approval to its commercial partner EddingPharm for the heart drug Vascepa.The approval was granted for Vascepa
Express News | Amarin's China Partner EddingPharm Receives Regulatory Approval From NMPA For VASCEPA In Mainland China For Cardiovascular Risk Reduction
Express News | Amarin Corp: Co Will Supply Product to Edding Under Negotiated Supply Terms
Express News | Amarin Corp: Edding Will Pay Co Tiered Double-Digit Percentage Royalties on Net Sales of Vascepa in China
Express News | Amarin Corp: Based Upon Nmpa Approval for Cvrr Indication, Will Earn Milestone Payment of $15 Mln
Express News | Amarin Partner Eddingpharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (Cvrr)